Answers are grounded in this paper and cite their sources.
Sodium cephalothin (Keflin) has been extensively used in the therapy of gram-negative and gram-positive infections with but few untoward reactions. In a few cases hematological side effects, ie, transient neutropenia—associated in one case with the bone marrow manifestation of maturation arrest, have been reported. Cessation of cephalothin therapy was associated with a prompt recovery from the neutropenia.1 Our interest in cephalothin began with the case of a 16-year-old boy with anemia and uremia due to congenital absence of one kidney and hypoplasia of the other. He had a positive direct Coombs' (antiglobulin) test without evidence of any blood-cell antibodies in his serum. No antibody could be eluted from his erythrocytes. He was receiving cephalothin intravenously, and the possibility of a serologic abnormality associated with a specific antibody to this drug or cross-reacting anti-peni-cillin antibody was considered. To investigate this possibility, we studied the sera and red blood cells (RBCs)
No takes yet. Share an insight, caveat, or question.
Harvey R. Gralnick (1967) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: